Written by the Nuvirox Research Team
Key points
- Liposomal delivery wraps a nutrient in tiny fat bubbles to protect it through digestion. It demonstrably improves absorption for some nutrients, like vitamin C.
- NAD+ faces a second barrier even if delivery works: intact NAD+ can't readily enter cells and must be broken down to a precursor first — so better gut survival doesn't solve the core problem.
- There are no solid oral human trials showing liposomal NAD+ reliably raises NAD+, and independent testing has flagged quality and labeling problems. Precursors remain the route with the evidence.
Short answer: liposomal delivery is a legitimate technology, but for NAD+ specifically the human evidence doesn't yet back the marketing — and there's a structural reason it may never be the shortcut it's sold as. Liposomes can shield fragile molecules from stomach acid and digestive enzymes, and for nutrients like vitamin C that improves absorption in controlled trials. The trouble with liposomal NAD+ is twofold: NAD+ itself is poorly suited to crossing into cells even once it's in the blood, and NAD+ is hard to keep stable inside a liposome through manufacturing and shelf life. The fair reading is that liposomal NAD+ is an interesting idea that hasn't earned the claims on the label.
What does "liposomal" actually mean?
A liposome is a microscopic bubble made of phospholipids — the same kind of fat that forms your cell membranes. The idea is to tuck a fragile or poorly absorbed nutrient inside that bubble so it survives the harsh trip through the stomach and gut, then releases its cargo once absorbed. It's a real and useful strategy: encapsulation can protect a compound from acid and enzymes and help it cross the intestinal lining.
Crucially, "liposomal" is a delivery claim, not a guarantee of results. Whether it helps depends entirely on the specific molecule — how unstable it is, how well it's normally absorbed, and whether the liposome actually survives manufacturing intact. For some nutrients the answer is yes; for NAD+, the picture is more complicated.
Does liposomal delivery work for anything?
Yes — for the right nutrient. The clearest example is vitamin C. In a randomized, double-blind, placebo-controlled crossover trial, 27 adults took 500 mg of standard or liposomal vitamin C; the liposomal form produced roughly 27% higher peak plasma concentration and about 21% greater total exposure than standard vitamin C (Purpura et al., 2024). That's a real, measurable bioavailability gain, and it's why "liposomal" isn't snake oil as a concept.
But notice what made vitamin C a good candidate: it's water-soluble, normally has limited absorption, and — most importantly — once it reaches the blood, your cells can use it directly. NAD+ fails that last test, which is the crux of the problem.
Why liposomal NAD+ runs into two barriers, not one
Barrier one: surviving the gut. This is the problem liposomes are designed to solve, and in theory encapsulation could help NAD+ survive digestion better than a bare NAD+ capsule. Fair enough — but that only gets the molecule into the bloodstream.
Barrier two: getting into cells. This is the one delivery can't fix. Intact NAD+ is a large, charged molecule that doesn't readily cross cell membranes; to be used, it generally has to be broken down to a precursor (like NR) outside the cell and rebuilt into NAD+ inside. So even a perfectly delivered dose of intact NAD+ faces a wall at the cell door. This is the same reason oral NAD+ capsules are the weakest option in the first place, and why the supplement industry settled on precursors — a point we cover in our overview of NAD+ supplements and in NR vs. NMN vs. NAD+.
What does the evidence on liposomal NAD+ actually show?
Thin is the honest word. Unlike NR and NMN — which have multiple placebo-controlled human trials showing they raise blood NAD+ (Conze et al., 2019; Martens et al., 2018) — liposomal NAD+ has no comparable body of oral human trials demonstrating it reliably raises NAD+ in people. The most relevant liposomal-NAD+ research to date has been in cells and skin models rather than in humans swallowing a supplement, which is interesting for early formulation science but does not establish a real-world benefit you'd feel.
There's also a quality wrinkle. Independent laboratory analyses of products marketed as "liposomal NAD+" have repeatedly found problems — some softgels contained little or no detectable NAD+, and several "liposomal" products contained only liposome ingredients (like lecithin or sunflower oil) without forming actual liposomal structures. NAD+ is chemically unstable in watery liposomal formulations, and common manufacturing steps can break the liposomes down, which makes the label claim hard to deliver on in practice. The takeaway isn't that liposomes are fake; it's that "liposomal NAD+" is a claim worth scrutinizing rather than trusting on faith.
| Claim | The honest reality |
|---|---|
| "Liposomal delivery boosts absorption" | True for some nutrients (e.g. vitamin C). Not demonstrated for NAD+ in oral human trials. |
| "It gets NAD+ into your cells" | Intact NAD+ struggles to enter cells regardless of delivery; it generally must convert to a precursor first. |
| "60% bioavailability" | A marketing figure, not a result from a controlled oral NAD+ trial in humans. |
| "Liposomal = better than precursors" | Reversed: NR and NMN have the human NAD+-raising data; liposomal NAD+ does not. |
What liposomal NAD+ won't do (and a note on shopping)
It won't reverse aging, and on current evidence it can't be assumed to raise NAD+ the way precursors do. If your goal is to support NAD+, the better-evidenced choice is a quality precursor at a studied dose. If you're specifically drawn to a needle-free way to get "NAD+ itself," it's worth knowing the other direct-NAD+ route — IV infusions — also rests on limited human data, which we cover in NAD+ injection benefits.
When you shop, the failure modes here are mostly quality ones: products that don't contain what they claim, or "liposomal" formulations that aren't really liposomal. Prioritize brands that are transparent about their ingredient, dose, and testing — our buyer's guide walks through how to judge that. And as always, if you're chasing NAD+ to fix fatigue or another symptom, rule out medical causes with a doctor first.
Frequently asked questions
Is liposomal NAD+ better than NR or NMN?
On the evidence, no. NR and NMN have multiple human trials showing they raise NAD+; liposomal NAD+ doesn't have a comparable oral human trial record. Better-sounding delivery doesn't beat a precursor that's actually been shown to work.
If liposomal vitamin C works, why not liposomal NAD+?
Because vitamin C only had one barrier — surviving digestion — and your cells use it directly. NAD+ has a second barrier: intact NAD+ can't easily enter cells and must convert to a precursor first. Delivery solves the first problem, not the second.
Are liposomal NAD+ products even real liposomes?
Not always. Independent testing has found products labeled "liposomal" that contained only liposome ingredients without forming true liposomal structures, and some that contained little detectable NAD+. It's a category where quality varies a lot.
So is liposomal NAD+ a scam?
Not necessarily — the technology is real and the science is early. But the marketing claims outrun the human evidence, so treat strong promises skeptically and favor the better-studied precursors.
What should I take instead?
A quality NAD+ precursor (NR or NMN) at a dose used in published trials. See our overview of NAD+ supplements and the benefits the evidence supports.
From Nuvirox
Why we formulated NAD+ Restore
Rather than chase a delivery gimmick, we built NAD+ Restore around the precursor the human evidence actually supports. Each 2-capsule serving delivers 500 mg of Nicotinamide Riboside Chloride (NR) — one of the two most-researched NAD+ precursors, within the dose range used in published human trials. Alongside it sit 150 mg trans-resveratrol (Japanese Knotweed) and 50 mg quercetin (Sophora japonica) — polyphenols studied alongside NAD+ pathways for cellular health support — plus 10 mg galactomannans from fenugreek to support absorption.
It comes with a 60-day money-back guarantee — long enough to actually evaluate it the way the research says you should.
Learn more about NAD+ Restore →The bottom line
Liposomal delivery is a real, useful technology — for the right molecule. NAD+ isn't an obvious fit, because it faces a second barrier delivery can't solve: even well-absorbed intact NAD+ struggles to enter cells and must convert to a precursor first. Add in NAD+'s instability inside liposomes and the documented quality problems in this product category, and the "liposomal NAD+" pitch starts to look like marketing running ahead of science. If the goal is to support NAD+, the evidence still points to a quality precursor, not a fancier wrapper around a molecule your cells can't easily use.
References
- Purpura M, Jäger R, Godavarthi A, Bhaskarachar D, Tinsley GM. Liposomal delivery enhances absorption of vitamin C into plasma and leukocytes: a double-blind, placebo-controlled, randomized trial. Eur J Nutr. 2024;63(8):3037–3046. DOI: 10.1007/s00394-024-03487-8. PMCID: PMC11519160.
- Conze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Sci Rep. 2019;9(1):9772. DOI: 10.1038/s41598-019-46120-z.
- Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286. DOI: 10.1038/s41467-018-03421-7.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.